CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Clinical trials for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial tests drug to control mysterious blood disorder
Disease control Recruiting nowThis study is testing whether a drug called enasidenib can safely help people with a condition called Clonal Cytopenia of Undetermined Significance (CCUS), which causes persistently low blood counts. Researchers think the drug might work by blocking a specific mutated protein fou…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Mega-Dose vitamin c joins fight against stubborn blood cancers
Disease control Recruiting nowThis study is testing if adding high-dose vitamin C (given through an IV) to standard chemotherapy can help patients whose lymphoma has returned or hasn't responded to treatment. It also tests vitamin C alone for certain pre-leukemia conditions. The goal is to see if vitamin C ma…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Targeted pill tested to control Pre-Leukemia blood disorders
Disease control Recruiting nowThis study is testing whether a pill called olutasidenib can help control certain early-stage blood disorders that have a specific genetic change (IDH1 mutation). It will involve about 15 adults with conditions like clonal cytopenia of undetermined significance (CCUS), lower-risk…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Could a simple shot stop a Pre-Cancerous blood condition from turning into cancer?
Prevention Recruiting nowThis study is testing whether a drug called canakinumab can prevent a high-risk blood condition (CCUS) from turning into blood cancer. About 110 adults with this condition will receive either the drug or a placebo injection to see if blocking inflammation delays or stops cancer d…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Prevention
Last updated Mar 20, 2026 14:47 UTC
-
Spice extract tested to soothe blood disorder symptoms
Symptom relief Recruiting nowThis study is testing whether a curcumin supplement, the active ingredient in turmeric, can reduce inflammation and improve symptoms in people with certain blood cell disorders. Researchers will compare the supplement to a placebo in 30 participants over 12 months. The main goals…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Genetic sleuthing aims to catch blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find people at risk for developing blood cancers and bone marrow failure syndromes before they get sick. Researchers will use advanced genetic testing on blood, bone marrow, and saliva samples from up to 2,000 participants. The goal is to identify early warning…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt clues to prevent blood cancers in cancer survivors
Knowledge-focused Recruiting nowThis study aims to understand why some people who have been treated for cancers like ovarian cancer later develop blood cancers or disorders. Researchers will observe 2,000 patients who have had certain cancer treatments to look for genetic and other risk factors. They will colle…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists launch Decade-Long hunt for clues in aging blood
Knowledge-focused Recruiting nowThis study aims to understand how certain genetic changes in blood cells, which can increase the risk of blood cancers and heart disease, develop over time. Researchers will follow about 300 adults with these changes for up to 10 years, performing regular health checks and scans.…
Matched conditions: CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC